| Announce Date | 10/21/2025 |
| EPS Normalized Actual | $0.82 (Beat by $0.041) |
| EPS GAAP Actual | $0.82 (Beat by $0.041) |
| Revenue Actual | $12.455B |
| Revenue Surprise | Beat by $12455M |
| Announce Date | 12/31/1969 (Pre-Market) |
| EPS Normalized Estimate | $ |
| EPS GAAP Estimate | $ |
| Revenue Estimate | $0B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2029 | 0 | INF | 0 | 0 | 2 |
| Dec 2028 | 3.7021 | 21.35 | 3.64524 | 3.76948 | 2 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 0.86 | 0.86 | 12.455B | 4.83% | 12455M |
| FQ2 2025 (Jun 2025) | 0.89 | 0.89 | 12.535B | 1.37% | 12535M |
| FQ1 2025 (Mar 2025) | 0.77 | 0.77 | 11.129B | -1.54% | 11129M |
| FQ4 2024 (Dec 2024) | 0.51 | 0.51 | 11.544B | 6.02% | 11544M |
| FQ3 2024 (Sep 2024) | 0.66 | 0.66 | 11.854B | -0.84% | 11854M |
| FQ2 2024 (Jun 2024) | 0.56 | 0.56 | 12.363B | 3.16% | 12363M |
| FQ1 2024 (Mar 2024) | 0.74 | 0.74 | 11.3B | 2.83% | 11300M |
| FQ4 2023 (Dec 2023) | 0.46 | 0.46 | 10.849B | 6.67% | 10849M |
FQ4 Announce Date
12/31/1969 (Pre-Market)
Consensus EPS Estimates
Consensus Revenue Estimates
0B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2028 (Dec 2028) | 0.638 | -- | 0.60824 | 0.65548 | 4 |
| FQ3 2028 (Sep 2028) | 0.9558 | -- | 0.91122 | 0.98199 | 6 |
| FQ2 2028 (Jun 2028) | 1.0685 | -- | 1.01866 | 1.09778 | 4 |
| FQ1 2028 (Mar 2028) | 0.9791 | -- | 0.93343 | 1.00593 | 6 |
| FQ4 2027 (Dec 2027) | 0.62837 | -- | 0.59987 | 0.6548 | 3 |
| FQ3 2027 (Sep 2027) | 0.93291 | -- | 0.8906 | 0.97216 | 3 |
| FQ2 2027 (Jun 2027) | 1.0038 | -- | 0.95827 | 1.04603 | 6 |
| FQ1 2027 (Mar 2027) | 0.82794 | -- | 0.80733 | 0.86173 | 5 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2028 (Dec 2028) | 13.03B | -- | 12.56B | 13.31B | 2 |
| FQ3 2028 (Sep 2028) | 14.25B | -- | 13.74B | 14.55B | 2 |
| FQ2 2028 (Jun 2028) | 14.74B | -- | 14.22B | 15.06B | 2 |
| FQ1 2028 (Mar 2028) | 14.12B | -- | 13.61B | 14.42B | 2 |
| FQ4 2027 (Dec 2027) | 12.25B | -- | 11.82B | 12.65B | 4 |
| FQ3 2027 (Sep 2027) | 13.37B | -- | 12.91B | 13.81B | 6 |
| FQ2 2027 (Jun 2027) | 13.71B | -- | 13.23B | 14.15B | 4 |
| FQ1 2027 (Mar 2027) | 12.36B | -- | 12.12B | 12.75B | 5 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
8
EPS # of Misses
0
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 0.86 | 0.86 | 100% | |
| FQ2 2025 (Jun 2025) | 0.89 | 0.89 | 100% | |
| FQ1 2025 (Mar 2025) | 0.77 | 0.77 | 100% | |
| FQ4 2024 (Dec 2024) | 0.51 | 0.51 | 100% | |
| FQ3 2024 (Sep 2024) | 0.66 | 0.66 | 100% | |
| FQ2 2024 (Jun 2024) | 0.56 | 0.56 | 100% | |
| FQ1 2024 (Mar 2024) | 0.74 | 0.74 | 100% | |
| FQ4 2023 (Dec 2023) | 0.46 | 0.46 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | $0B | $12.46B | $12455M | 100% |
| FQ2 2025 (Jun 2025) | $0B | $12.54B | $12535M | 100% |
| FQ1 2025 (Mar 2025) | $0B | $11.13B | $11129M | 100% |
| FQ4 2024 (Dec 2024) | $0B | $11.54B | $11544M | 100% |
| FQ3 2024 (Sep 2024) | $0B | $11.85B | $11854M | 100% |
| FQ2 2024 (Jun 2024) | $0B | $12.36B | $12363M | 100% |
| FQ1 2024 (Mar 2024) | $0B | $11.3B | $11300M | 100% |
| FQ4 2023 (Dec 2023) | $0B | $10.85B | $10849M | 100% |